Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.

Curaleaf launched a hostile takeover bid for Aurora Cannabis at $4 per share in August 2026, which Aurora rejected as undervalued. The situation has escalated with Curaleaf attempting to block Aurora's ability to raise capital through stock sales. With the tender offer open until December 1, significant animosity between the companies makes integration difficult if the acquisition succeeds, while Aurora shareholders face uncertainty about whether to accept the offer or hold for potential higher valuations.